166 related articles for article (PubMed ID: 34203220)
1. Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma.
Hering NA; Liu V; Kim R; Weixler B; Droeser RA; Arndt M; Pozios I; Beyer K; Kreis ME; Seeliger H
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34203220
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic Acetylcholine Receptor M3 Expression and Survival in Human Colorectal Carcinoma-An Unexpected Correlation to Guide Future Treatment?
Lobbes LA; Schütze MA; Droeser R; Arndt M; Pozios I; Lauscher JC; Hering NA; Weixler B
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175905
[TBL] [Abstract][Full Text] [Related]
3. Blocking Muscarinic Receptor 3 Attenuates Tumor Growth and Decreases Immunosuppressive and Cholinergic Markers in an Orthotopic Mouse Model of Colorectal Cancer.
Kuol N; Davidson M; Karakkat J; Filippone RT; Veale M; Luwor R; Fraser S; Apostolopoulos V; Nurgali K
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614038
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines.
Kuol N; Godlewski J; Kmiec Z; Vogrin S; Fraser S; Apostolopoulos V; Nurgali K
BMC Cancer; 2023 Oct; 23(1):971. PubMed ID: 37828429
[TBL] [Abstract][Full Text] [Related]
5. Effects of modulating M3 muscarinic receptor activity on azoxymethane-induced liver injury in mice.
Khurana S; Jadeja R; Twaddell W; Cheng K; Rachakonda V; Saxena N; Raufman JP
Biochem Pharmacol; 2013 Jul; 86(2):329-38. PubMed ID: 23707755
[TBL] [Abstract][Full Text] [Related]
6. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
Song P; Sekhon HS; Lu A; Arredondo J; Sauer D; Gravett C; Mark GP; Grando SA; Spindel ER
Cancer Res; 2007 Apr; 67(8):3936-44. PubMed ID: 17440109
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation.
Yu H; Xia H; Tang Q; Xu H; Wei G; Chen Y; Dai X; Gong Q; Bi F
Sci Rep; 2017 Jan; 7():40802. PubMed ID: 28102288
[TBL] [Abstract][Full Text] [Related]
8. Activation of M3 muscarinic receptor by acetylcholine promotes non-small cell lung cancer cell proliferation and invasion via EGFR/PI3K/AKT pathway.
Xu R; Shang C; Zhao J; Han Y; Liu J; Chen K; Shi W
Tumour Biol; 2015 Jun; 36(6):4091-100. PubMed ID: 25964092
[TBL] [Abstract][Full Text] [Related]
9. [M3 Muscarnic Receptor Antagonist Mediates Cell Proliferation Apoptosis
and Adhesion in Small Cell Lung Cancer].
Wu W; Zhang S; Hu C
Zhongguo Fei Ai Za Zhi; 2016 Mar; 19(3):113-21. PubMed ID: 27009814
[TBL] [Abstract][Full Text] [Related]
10. Targeting M3 Muscarinic Receptors for Colon Cancer Therapy.
Felton J; Hu S; Raufman JP
Curr Mol Pharmacol; 2018; 11(3):184-190. PubMed ID: 29357811
[TBL] [Abstract][Full Text] [Related]
11. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.
Said AH; Hu S; Abutaleb A; Watkins T; Cheng K; Chahdi A; Kuppusamy P; Saxena N; Xie G; Raufman JP
Biochem J; 2017 Feb; 474(5):647-665. PubMed ID: 28008134
[TBL] [Abstract][Full Text] [Related]
12. Evidence for enhanced M3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2-deficient mouse.
Tuomi JM; Chidiac P; Jones DL
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H554-61. PubMed ID: 19966055
[TBL] [Abstract][Full Text] [Related]
13. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
[TBL] [Abstract][Full Text] [Related]
14. Choline Attenuates Cardiac Fibrosis by Inhibiting p38MAPK Signaling Possibly by Acting on M
Zhao L; Chen T; Hang P; Li W; Guo J; Pan Y; Du J; Zheng Y; Du Z
Front Pharmacol; 2019; 10():1386. PubMed ID: 31849653
[TBL] [Abstract][Full Text] [Related]
15. Vasodilatory effects of cholinergic agonists are greatly diminished in aorta from M3R-/- mice.
Khurana S; Chacon I; Xie G; Yamada M; Wess J; Raufman JP; Kennedy RH
Eur J Pharmacol; 2004 Jun; 493(1-3):127-32. PubMed ID: 15189773
[TBL] [Abstract][Full Text] [Related]
16. R2-8018 reduces the proliferation and migration of non-small cell lung cancer cells by disturbing transactivation between M3R and EGFR.
Lan L; Wang H; Yang R; Liu F; Bi Q; Wang S; Wei X; Yan H; Su R
Life Sci; 2019 Oct; 234():116742. PubMed ID: 31401315
[TBL] [Abstract][Full Text] [Related]
17. Effect of M3 muscarinic acetylcholine receptor deficiency on collagen antibody-induced arthritis.
Beckmann J; Dittmann N; Schütz I; Klein J; Lips KS
Arthritis Res Ther; 2016 Jan; 18():17. PubMed ID: 26785775
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of M3 muscarinic receptors in progressive colon neoplasia and metastasis.
Cheng K; Shang AC; Drachenberg CB; Zhan M; Raufman JP
Oncotarget; 2017 Mar; 8(13):21106-21114. PubMed ID: 28416748
[TBL] [Abstract][Full Text] [Related]
19. Teaching an Old Drug New Tricks: Agonism, Antagonism, and Biased Signaling of Pilocarpine through M3 Muscarinic Acetylcholine Receptor.
Pronin AN; Wang Q; Slepak VZ
Mol Pharmacol; 2017 Nov; 92(5):601-612. PubMed ID: 28893976
[TBL] [Abstract][Full Text] [Related]
20. Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).
Zhao Q; Gu X; Zhang C; Lu Q; Chen H; Xu L
Cancer Biol Ther; 2015; 16(4):634-43. PubMed ID: 25778781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
